Somalogic stock.

Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools. GlobeNewswire 61d. Start Trading >> …

Somalogic stock. Things To Know About Somalogic stock.

SomaLogic is a protein biomarker discovery and clinical diagnostics company located in Boulder, Colorado. It became listed on Nasdaq in September 2021 with a merger with the special-purpose acquisition company CM Life Sciences II, Inc. [2] The SomaLogic team provided more than 28 million data points from the assay which will be combined with other available genetic, ... Recent action in Nvidia stock points to consolidation.Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …Somalogic Inc stock performance at a glance. Check Somalogic Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. SLGC Stock Performance. USD USD; Previous close: 2.75: 2.75: Day range: 2.71 - 2.862.71 - 2.86Year range: 1 - 31 - 3Market cap: 517,198,000:Aug 12, 2021 · The ownership percentages with respect to the post-combination and PIPE Investment are based on aggregate Merger Consideration of 125,000,000 shares of CMLS II Class A Common Stock (assuming no cash elections will be made by SomaLogic stockholders) and assume 116,013,417 shares will be issued at Closing to current holders of issued and ...

Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today reported financial results for the third quarter …When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.Mar 28, 2023 · SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized ...

If you hold stock certificates in your name, please contact our transfer agent, Continental, at 1-877-634-5370. ... Does SomaLogic have a direct stock purchase plan? Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …

SomaLogic is a protein biomarker discovery and clinical diagnostics company located in Boulder, Colorado. It became listed on Nasdaq in September 2021 with a merger with the special-purpose acquisition company CM Life Sciences II, Inc. [2]A high-level overview of SomaLogic, Inc. (SLGC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Information concerning SomaLogic’s directors and executive officers, including their ownership of SomaLogic securities, is set forth in the joint proxy statement/prospectus, SomaLogic’s proxy statement for its 2023 Annual Meeting of Stockholders, which was filed with the SEC on April 25, 2023, Current Reports on Form …SomaLogic (Nasdaq: SLGC) is fostering the discovery of effective and safer treatments for patients in need while empowering more accurate diagnosis, prevention, and treatment of disease through the next generation of proteomics. Powered by an industry-leading technology platform comprised of both assay services and diagnostics in combination ...SomaLogic will host a conference call at 4:30 p.m. ET on Monday, August 14, 2023 to discuss its second quarter 2023 financial results. Those interested in listening to the conference call should ...

Income Statement for Somalogic Inc (SLGC) with Annual and Quarterly reports. Income Statement for Somalogic Inc (SLGC) ... Stock Market Overview Market Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & Dividends Stock Screener.

12/04/2023 - 08:00 AM. SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – and SomaLogic, Inc. (Nasdaq: SLGC), a leader in data-driven proteomics technology, today announced that the ...

Standard BioTools (LAB) will acquire SomaLogic Inc. (SLGC) in an all-stock deal. For each share of SomaLogic stock, shareholders will receive 1.11 shares of Standard BioTools stock. After the acquisition, SomaLogic shareholders will own about 57% of the combined company while 43% would be owned by Standard BioTools …Oct 4, 2023 · Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and affiliated investment funds, have entered into voting agreements in support of the transaction. Full 2023 Year Outlook Following the transaction, the combined company was renamed SomaLogic, Inc., and its Class A common stock and warrants will begin trading on the Nasdaq Global Market (“Nasdaq”) on September 2, 2021 under the symbols “SLGC” and “SLGCW,” respectively.Aug 15, 2023 · Shares of SomaLogic (SLGC-0.35%) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock ... Under the terms of the all-stock deal, SomaLogic investors are to receive 1.11 common shares of Standard BioTools stock for each SomaLogic common share they hold. When the merger closes, SomaLogic ...Another stock from the same industry, SomaLogic, Inc. (SLGC), has yet to report results for the quarter ended December 2022. The results are expected to be released on March 28.28 nov 2022 ... SomaLogic, Inc.(NASDAQ:SLGC): Well-known investor Cathie Wood has recently bought shares of healthcare company SomaLogic (SLGC) for less ...

Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and affiliated investment funds, have entered into voting agreements in support of the transaction. Full 2023 Year Outlook. In connection with …Get the latest SomaLogic, Inc. (SLGC) stock quote, history, news and other vital information to help you with your stock trading and investing. See the performance …Oct 4, 2023 · SomaLogic Inc.'s (SLGC) stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger with ... Dec 4, 2023 · Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools. GlobeNewswire 61d. Start Trading >> Plus500. 81% of retail CFD accounts lose money. SomaLogic, Inc. announced that it is extending its collaborative agreement with Novo Nordisk. As part of the agreement, which now extends into the end of 2025, Novo Nordisk will expand its use of the...With the stock on the backfoot, Wood evidently thinks it offers good value. Ark Invest opened a new position in SomaLogic in Q3 and snapped up 11,017,672 shares. These are currently worth over $29 ...

Filing of certain prospectuses and communications in connection with business combination transactions. Other. 0001104659-23-106611.pdf. 0001104659-23-106611.rtf. 0001104659-23-106611.xls. View HTML. Oct 04, 2023. 425. Filing of certain prospectuses and communications in connection with business combination transactions.

He currently serves as Chairman of SomaLogic, a company that he founded and formerly served as CEO. ... The most recent stock trade was executed by Asset Management Llp Oxford on 9 October 2019, trading 699,900 units of KBLM stock currently worth $7,355,949.Sep 1, 2021 · Following the transaction, the combined company was renamed SomaLogic, Inc., and its Class A common stock and warrants will begin trading on the Nasdaq Global Market (“Nasdaq”) on September 2 ... Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, …The stock is currently trading at $2.47 and its $5.06 average price target implies ~105% upside potential by the end of this year. (See BFLY stock forecast ) SomaLogic, Inc. ( SLGC )The average Somalogic stock price prediction forecasts a potential downside of 2.04% from the current SLGC share price of $2.45. What is SLGC's forecast return on assets (ROA) for 2023-2025? (NASDAQ: SLGC) forecast ROA is -9.99%, which is lower than the forecast US Health Information Services industry average of 8.41%.SomaLogic, Inc. is a commercial-stage proteomics company. The Company has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate ...

SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – and SomaLogic, Inc. (Nasdaq: SLGC), a leader in data-driven proteomics technology, today announced that the companies have set a date for their respective Special Meetings of ...

BOULDER — SomaLogic Inc. (Nasdaq: SLGC) and California-based Standard BioTools Inc. (Nasdaq: LAB) have agreed to an all-stock merger deal that is expected to result in a combined company valued at more than $1 billion. Existing executives with both companies will lead the combined organization, which will carry the Standard BioTools name.

What is the target price for SomaLogic (SLGC) stock? The latest price target for SomaLogic ( NASDAQ: SLGC) was reported by Jefferies on Thursday, October 5, 2023. The analyst firm set a price ...Standard BioTools and SomaLogic will host a joint conference call and webcast today at 8:30 a.m. ET to discuss the merger. The conference call can be accessed by dialing (800) 225-9448 within the ...SomaLogic: A Look into Hedge Fund Activity and Stock Ratings SomaLogic Inc. (NASDAQ:SLGC) has recently caught the attention of large investors, as Mitchell Mcleod Pugh & Williams Inc. and Raymond James & Associates both bought new positions in the company worth $30,000 and $33,000 respectively.Oct 11, 2023 · "Based on stock prices, people don't seem to like this deal," said Kyle Mikson, an analyst with Canaccord Genuity who covers SomaLogic. "People knew Standard BioTools was going to buy something and SomaLogic makes a kind of sense, but I'm sure SomaLogic investors wanted a better premium and Standard BioTools investors wanted a more proven asset ... Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Nov 8, 2023 · SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November ... Under the terms of the all-stock deal, SomaLogic investors are to receive 1.11 common shares of Standard BioTools stock for each SomaLogic common share they hold. When the merger closes, SomaLogic ...Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0.001 per …

Information concerning SomaLogic’s directors and executive officers, including their ownership of SomaLogic securities, is set forth in the joint proxy statement/prospectus, SomaLogic’s proxy ...Raising full year 2023 revenue guidance to $82 million to $85 million. BOULDER, Colo., Nov. 08, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today reported recent business highlights and financial results for the quarter ended September 30, 2023. “We’re pleased to report another quarter of solid …Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and affiliated investment funds, have entered into voting agreements in support of the transaction. Full 2023 Year OutlookInstagram:https://instagram. top bullion dealersbest option brokersprecision optics corporationhow can i day trade without 25k on robinhood See the latest SomaLogic Inc Class A stock price (SLGC:XNAS), related news, valuation, dividends and more to help you make your investing decisions.According to 4 stock analysts, the average 12-month stock price forecast for SomaLogic stock is $4.70, which predicts an increase of 66.67%. The lowest target is $2.30 and the highest is $7.00. On average, analysts rate SomaLogic stock as a buy. loglysingle serving wine Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …Why SomaLogic Stock Dived by 10% on Wednesday The market wasn't impressed by the company's announced tie-up with Standard BioTools. Eric Volkman | Oct 4, 2023 forex practice accounts NEW YORK – Standard BioTools, formerly known as Fluidigm, and SomaLogic said on Wednesday that they will merge in an all-stock deal to create a company worth over $1 billion. Under the terms of the agreement, which was unanimously approved by the participating members of the boards of directors of both companies, …Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...